UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785

2013

Volltextzugriff (PDF)

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.2057-2067

2011

Volltextzugriff (PDF)

Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis

Annals of oncology, 2014-02, Vol.25 (2), p.529-536

2014

Volltextzugriff (PDF)

Simulations Using a Drug-Disease Modeling Framework and Phase II Data Predict Phase III Survival Outcome in First-Line Non-Small-Cell Lung Cancer

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.631-634

2012

Volltextzugriff (PDF)

Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors

JNCI : Journal of the National Cancer Institute, 2005-01, Vol.97 (1), p.59-69

2005

Volltextzugriff (PDF)

Characterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle

The Journal of biological chemistry, 1993-06, Vol.268 (18), p.13203-13213

1993

Volltextzugriff (PDF)

Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs

Molecular pharmacology, 1991-02, Vol.39 (2), p.233-238

1991

Volltextzugriff (PDF)

Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium

Diabetes (New York, N.Y.), 1995-10, Vol.44 (10), p.1147-1155

1995

Volltextzugriff (PDF)

Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes

Molecular and cellular biochemistry, 1998, Vol.178 (1/2), p.367-375

1998

Volltextzugriff (PDF)

Osteonecrosis of the Jaw and Bisphosphonates

The New England journal of medicine, 2005-07, Vol.353 (1), p.99-102

2005

Volltextzugriff (PDF)

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Journal of clinical oncology, 2005-08, Vol.23 (22), p.4925-4935

2005

Volltextzugriff (PDF)

Purification and characterization of a novel ribosomal S6 kinase from skeletal muscle of insulin-treated rats

The Journal of biological chemistry, 1994-03, Vol.269 (10), p.7816-7823

1994

Volltextzugriff (PDF)

Recent progress in insulin signal transduction

Journal of pharmacological and toxicological methods, 1998-10, Vol.40 (3), p.123-135

Hei, Yong-Jiang

1998

Volltextzugriff (PDF)

Distribution of MAP kinase, S6 kinase, and casein kinase II in rat tissues: activation by insulin in spleen

Biochemistry and cell biology, 1994-01, Vol.72 (1-2), p.49-53

1994

Volltextzugriff (PDF)

Nuclear localization conferred by the pocket domain of the retinoblastoma gene product

Biochimica et biophysica acta, 1999-09, Vol.1451 (2), p.288-296

1999

Volltextzugriff (PDF)

Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation

Oncogene, 1996-01, Vol.12 (1), p.43-52

1996

Volltextzugriff (PDF)

Predictive value of Fc gamma receptor IIIa genotype in response to conatumumab in three phase II studies

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3103-3103

2011

Volltextzugriff (PDF)

Phase 3 Study (MONET1) of Motesanib Plus Carboplatin/Paclitaxel (C/P) in Patients with Advanced NSCLC: Asian Subgroup Analysis

Annals of oncology, 2012-10, Vol.23, p.xi33-xi34

2012

Volltextzugriff (PDF)

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-06, Vol.29 (18_suppl), p.LBA7512-LBA7512

2011

Volltextzugriff (PDF)

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.LBA7512-LBA7512

2011

Volltextzugriff (PDF)

The effect of motesanib treatment on the gallbladder: A randomized phase Ib study in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13555-e13555

2011

Volltextzugriff (PDF)

2110 Efficacy outcomes by severity of skin toxicity from ASPECCT: Randomized phase 3 study of panitumumab (pmab) versus cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC)

European journal of cancer (1990), 2015-09, Vol.51, p.S366-S366

2015

Volltextzugriff (PDF)

Effects of zoledronic acid on survival in patients with lung cancer and high baseline N-telopeptide (NTX) levels: Stratified by baseline bone alkaline phosphatase (BALP)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7228-7228

2006

Volltextzugriff (PDF)

Predictors of clinical outcome in patients with bone metastases from prostate cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4555-4555

2006

Volltextzugriff (PDF)

Zoledronic acid versus pamidronate in patients with breast cancer and multiple myeloma who are at high risk for skeletal complications

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.857-857

2004

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(45)
Humans
(27)
Male
(27)
Animals
(21)
Female
(17)
Biological And Medical Sciences
(15)
Middle Aged
(13)
Oncology
(10)
Rats
(10)
Adult
(9)
Aged
(9)
Cell Biology
(9)
Medical Sciences
(9)
Biochemistry & Molecular Biology
(8)
Mice
(8)
Insulin - Pharmacology
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Nous Allons
(6)
Nous Avons
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis

Simulations Using a Drug-Disease Modeling Framework and Phase II Data Predict Phase III Survival Outcome in First-Line Non-Small-Cell Lung Cancer

Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors

Characterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle

Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs

Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium

Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes

Osteonecrosis of the Jaw and Bisphosphonates

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Purification and characterization of a novel ribosomal S6 kinase from skeletal muscle of insulin-treated rats

Recent progress in insulin signal transduction

Distribution of MAP kinase, S6 kinase, and casein kinase II in rat tissues: activation by insulin in spleen

Nuclear localization conferred by the pocket domain of the retinoblastoma gene product

Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation

Predictive value of Fc gamma receptor IIIa genotype in response to conatumumab in three phase II studies

Phase 3 Study (MONET1) of Motesanib Plus Carboplatin/Paclitaxel (C/P) in Patients with Advanced NSCLC: Asian Subgroup Analysis

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

The effect of motesanib treatment on the gallbladder: A randomized phase Ib study in patients (pts) with advanced solid tumors

2110 Efficacy outcomes by severity of skin toxicity from ASPECCT: Randomized phase 3 study of panitumumab (pmab) versus cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC)

Effects of zoledronic acid on survival in patients with lung cancer and high baseline N-telopeptide (NTX) levels: Stratified by baseline bone alkaline phosphatase (BALP)

Predictors of clinical outcome in patients with bone metastases from prostate cancer

Zoledronic acid versus pamidronate in patients with breast cancer and multiple myeloma who are at high risk for skeletal complications

Suchergebnisse filtern